Literature DB >> 23259317

Cardiovascular protection by curcumin: molecular aspects.

Georgia Kapakos1, Viktoria Youreva, Ashok K Srivastava.   

Abstract

Curcumin is the active component in turmeric--a spice that has been extensively used as a culinary agent and a home remedy to prevent and treat many diseases in India and other countries for hundreds of years. However, systematic studies to understand the molecular basis of disease preventing or therapeutic properties of curcumin began to appear in the scientific literature only during the last 40 years. As a result of these studies, substantial evidence has accumulated to suggest that curcumin can affect signaling pathways linked to cellular growth, proliferation, survival, inflammation and transcription. In addition, curcumin has also been shown to exert anti-atherosclerotic, anti-cancer, anti-diabetic, anti-inflammatory and anti-oxidative properties in animal models of various diseases and in human subjects. In this article, we highlight the cardiovascular protective role of curcumin with an emphasis on the molecular basis of this effect.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23259317

Source DB:  PubMed          Journal:  Indian J Biochem Biophys        ISSN: 0301-1208            Impact factor:   1.918


  13 in total

Review 1.  HbE/β-Thalassemia and Oxidative Stress: The Key to Pathophysiological Mechanisms and Novel Therapeutics.

Authors:  Rhoda Elison Hirsch; Nathawut Sibmooh; Suthat Fucharoen; Joel M Friedman
Journal:  Antioxid Redox Signal       Date:  2016-11-28       Impact factor: 8.401

2.  Neuroprotective Effect of Curcumin Against Cerebral Ischemia-Reperfusion Via Mediating Autophagy and Inflammation.

Authors:  Lifa Huang; Chengwei Chen; Xin Zhang; Xu Li; Zupeng Chen; Chao Yang; Xiaolong Liang; Guochong Zhu; Zhen Xu
Journal:  J Mol Neurosci       Date:  2017-12-15       Impact factor: 3.444

3.  Curcumin's Effect on Inflammatory Response following Percutaneous Coronary Intervention in Adult Patients with Stable Coronary Heart Disease.

Authors:  Todung Silalahi; Idrus Alwi; Frans Suyatna; Katarina D Sartika
Journal:  Int J Angiol       Date:  2021-01-29

4.  The Effect of Curcumin on some of Traditional and Non-traditional Cardiovascular Risk Factors: A Pilot Randomized, Double-blind, Placebo-controlled Trial.

Authors:  Parastoo Mirzabeigi; Amir Hooshang Mohammadpour; Mojtaba Salarifar; Kheirollah Gholami; Mojtaba Mojtahedzadeh; Mohammad Reza Javadi
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

Review 5.  Polyphenols: benefits to the cardiovascular system in health and in aging.

Authors:  Sandhya Khurana; Krishnan Venkataraman; Amanda Hollingsworth; Matthew Piche; T C Tai
Journal:  Nutrients       Date:  2013-09-26       Impact factor: 5.717

6.  Investigation of the effect of short-term supplementation with curcuminoids on circulating small dense low-density lipoprotein concentrations in obese dyslipidemic subjects: A randomized double-blind placebo-controlled cross-over trial.

Authors:  Mohsen Moohebati; Shima Yazdandoust; Amirhossein Sahebkar; Mohsen Mazidi; Zahra Sharghi-Shahri; Gordon Ferns; Majid Ghayour-Mobarhan
Journal:  ARYA Atheroscler       Date:  2014-09

Review 7.  Biochemistry, Safety, Pharmacological Activities, and Clinical Applications of Turmeric: A Mechanistic Review.

Authors:  Rabia Shabir Ahmad; Muhammad Bilal Hussain; Muhammad Tauseef Sultan; Muhammad Sajid Arshad; Marwa Waheed; Mohammad Ali Shariati; Sergey Plygun; Mohammad Hashem Hashempur
Journal:  Evid Based Complement Alternat Med       Date:  2020-05-10       Impact factor: 2.629

8.  Curcumin protects mice from Staphylococcus aureus pneumonia by interfering with the self-assembly process of α-hemolysin.

Authors:  Jianfeng Wang; Xuan Zhou; Wenhua Li; Xuming Deng; Yanhong Deng; Xiaodi Niu
Journal:  Sci Rep       Date:  2016-06-27       Impact factor: 4.379

9.  Effects of Preoperative Curcumin on the Inflammatory Response During Mechanical Circulatory Support: A Porcine Model.

Authors:  Peter Ma; Dmitry Tumin; Mary Cismowski; Joseph D Tobias; Daniel Gomez; Patrick McConnell; Aymen Naguib; Andrew R Yates; Peter Winch
Journal:  Cardiol Res       Date:  2018-02-11

10.  Nano-curcumin improves glucose indices, lipids, inflammation, and Nesfatin in overweight and obese patients with non-alcoholic fatty liver disease (NAFLD): a double-blind randomized placebo-controlled clinical trial.

Authors:  Seyed Ali Jazayeri-Tehrani; Seyed Mahdi Rezayat; Siavash Mansouri; Mostafa Qorbani; Seyed Moayed Alavian; Milad Daneshi-Maskooni; Mohammad-Javad Hosseinzadeh-Attar
Journal:  Nutr Metab (Lond)       Date:  2019-01-28       Impact factor: 4.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.